Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Eur J Med Chem
; 69: 768-78, 2013 Nov.
Article
em En
| MEDLINE
| ID: mdl-24099996
ABSTRACT
In order to find the vitamin D receptor (VDR) ligand whose VDR agonistic activity is separated from the calcemic activity sufficiently, novel nonsecosteroidal analogs with phenyl-pyrrolyl pentane skeleton were synthesized and evaluated for the VDR binding affinity, antiproliferative activity in vitro and serum calcium raising ability in vivo (tacalcitol used as control). Among them, several compounds showed varying degrees of VDR agonistic and growth inhibition activities of the tested cell lines. The most effective compound 2g (EC50 1.06 nM) exhibited stronger VDR agonistic activity than tacalcitol (EC50 7.05 nM), inhibited the proliferations of HaCaT and MCF-7 cells with IC50 of 2.06 µM and 0.307 µM (tacalcitol 2.07 µM and 0.057 µM) and showed no significant effect on serum calcium.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pirróis
/
Butanonas
/
Receptores de Calcitriol
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Eur J Med Chem
Ano de publicação:
2013
Tipo de documento:
Article